Adicet Bio
ACET
Adicet Bio (ACET) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$5.44
- EPS estimate
- −$4.86
- EPS surprise
- −11.90%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 7, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 7, 2025 | −$4.86 | −$5.44 | −11.90% | $0.00 | SEC |
| Q1 2025 | May 6, 2025 | −$5.31 | −$4.96 | +6.53% | $0.00 | SEC |
| Q4 2024 | Mar 6, 2025 | −$5.71 | −$5.12 | +10.28% | $0.00 | SEC |
| Q3 2024 | Nov 6, 2024 | −$5.45 | −$5.44 | +0.15% | $0.00 | SEC |
| Q2 2024 | Aug 13, 2024 | −$5.82 | −$5.28 | +9.31% | $0.00 | SEC |
| Q1 2024 | May 14, 2024 | −$7.18 | −$5.60 | +21.96% | $0.00 | SEC |
| Q4 2023 | Mar 19, 2024 | −$11.15 | −$11.04 | +0.96% | $0.00 | SEC |
| Q3 2023 | Nov 8, 2023 | −$11.79 | −$18.56 | −57.39% | $0.00 | SEC |
| Q2 2023 | Aug 9, 2023 | −$7.36 | −$12.00 | −63.04% | $0.00 | SEC |
| Q1 2023 | May 9, 2023 | −$9.22 | −$11.52 | −24.95% | $0.00 | SEC |
| Q4 2022 | Mar 15, 2023 | −$4.48 | −$11.52 | −157.14% | $0.00 | SEC |
| Q3 2022 | Nov 8, 2022 | −$8.51 | −$8.48 | +0.34% | $0.00 | SEC |
| Q2 2022 | Aug 10, 2022 | −$7.28 | −$8.96 | −23.08% | $0.00 | SEC |
| Q1 2022 | May 12, 2022 | −$2.91 | $1.60 | +154.95% | $25.0M | SEC |
| Q4 2021 | Mar 15, 2022 | −$6.74 | −$7.52 | −11.57% | $5.5M | SEC |
| Q3 2021 | Nov 10, 2021 | −$6.88 | −$7.04 | −2.33% | $3.4M | SEC |
| Q2 2021 | Aug 12, 2021 | −$8.34 | −$5.44 | +34.79% | $4.8M | SEC |
| Q1 2021 | May 17, 2021 | −$7.68 | −$13.12 | −70.83% | −$4.0M | SEC |
| Q4 2020 | Mar 11, 2021 | −$12.80 | −$7.36 | +42.50% | $5.4M | SEC |
| Q3 2020 | Nov 5, 2020 | −$23.36 | −$45.44 | −94.52% | $3.0M | SEC |
Quarterly revenue
Frequently asked questions
When did Adicet Bio (ACET) last report earnings?
Adicet Bio last reported on Aug 7, 2025, covering fiscal Q2 2025.
Did ACET beat earnings estimates?
No. Adicet Bio reported EPS of −$5.44 for Q2 2025 against a −$4.86 estimate — a 11.90% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.